55296-17-8

Basic information

• Product Name: 3-AMINO-4-PHENYLAMINO-BENZOIC ACID
• Synonyms: 3-AMINO-4-PHENYLAMINO-BENZOIC ACID
• CAS NO: 55296-17-8
• Molecular Formula: C₁₃H₁₂N₂O₂
• Molecular Weight: 228.24658
• Mol File: 55296-17-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 441°C at 760 mmHg
• Flash Point: 220.5°C
• Appearance: /
• Density: 1.34g/cm³
• Vapor Pressure: 1.48E-08mmHg at 25°C
• Refractive Index: 1.713
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-AMINO-4-PHENYLAMINO-BENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-AMINO-4-PHENYLAMINO-BENZOIC ACID(55296-17-8)
• EPA Substance Registry System: 3-AMINO-4-PHENYLAMINO-BENZOIC ACID(55296-17-8)

Safety Data

• Hazardous Substances Data: 55296-17-8(Hazardous Substances Data)

Usage

Uses

3-Amino-4-(phenylamino)benzoic Acid (cas# 55296-17-8) is used as a potent and selective human prostaglandin E2 receptor subtype 4 (hEP4-R) antagonist for treatment of endometriosis

InChI:InChI=1/C13H12N2O2/c14-11-8-9(13(16)17)6-7-12(11)15-10-4-2-1-3-5-10/h1-8,15H,14H2,(H,16,17)

Upstream product

• 2365-85-7 3-amino-4-fluorobenzoic acid 
• 62-53-3 aniline 
• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 96-99-1 4-chloro-3-nitrobenzoate 
• 16927-49-4 2-nitrodiphenylamine-4-carboxylic acid 

Downstream Products

• 534-85-0 N-phenyl-1,2-benzenediamine 
• 56886-52-3 2-(2-methyl-1-phenyl-1H-benzoimidazol-5-yl)-benzothiazole 
• 56886-60-3 2-(2-methyl-1-phenyl-1H-benzoimidazol-5-yl)-benzooxazole 
• 21720-24-1 2'-methyl-1'-phenyl-1H,1'H-[2,5']bi[benzoimidazolyl] 
• 1256966-55-8 5-(benzothiazol-2-yl)-1-phenyl-2-(phenylmethoxy)methylbenzimidazole 
• 1256966-56-9 5-(benzothiazol-2-yl)-2-hydroxymethyl-1-phenylbenzimidazole 
• 1256966-57-0 5-(benzothiazol-2-yl)-2-(N,N-dimethylammo)methyl-1-phenylbenzimidazole 
• 92437-43-9 2-methyl-1-phenyl-1H-benzoimidazole-5-carboxylic acid 
• 356099-06-4 1-phenyl-1H-benzotriazole-5-carboxylic acid 
• 514206-06-5 3-amino-4-phenylaminobenzoic acid methyl ester 

Relevant articles and documents

Structural Modifications of Benzimidazoles via Multi-Step Synthesis and Their Impact on Sirtuin-Inhibitory Activity

Benzimidazole derivatives have been shown to possess sirtuin-inhibitory activity. In the continuous search for potent sirtuin inhibitors, systematic changes on the terminal benzene ring were performed on previously identified benzimidazole-based sirtuin i

AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS

A compound depicted by the formula below, or a pharmaceutically acceptable salt or solvate thereof. wherein, R1 represents (1) a C3-6 alkyl group,(2) a C1-6 alkyl group substituted with one or more substituent group(s) sel